Clinical trial No longer in our active list Early Phase 1 Interventional Ages 18 and up

Using erector spinae plane block for pain control

Official title: Erector Spinae Regional Anesthesia for Pain Control in the Emergency Department

Run by The University of Texas Health Science Center at San Antonio · NCT05794828 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a special pain relief technique called the erector spinae plane block can help people with various painful conditions feel better and use less pain medication.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorThe University of Texas Health Science Center at San Antonio
Academic / other
Locations4 sites (Ridley Park, Pennsylvania and 3 other locations)
Trial IDNCT05794828 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with posterior or lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, or back pain.

Probably not a fit

Patients with unstable vital signs, infections at the injection site, prior allergic reactions to local anesthetics, pregnant females, individuals under 18, or those with altered mentation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to evaluate the effectiveness of the erector spinae plane block (ESPB) in managing pain for patients with conditions such as rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain. Patients will receive an ultrasound-guided ESPB and will report their pain levels before and 30 minutes after the procedure. Additionally, the study will track the total opiate use of patients for up to 8 hours following the block to assess its impact on pain management and opioid consumption.

Why it matters

Potential benefit: If successful, this approach could significantly reduce pain and decrease reliance on opioids for patients with severe pain conditions.

How similar studies have gone: Other studies have shown promising results with similar approaches using erector spinae plane blocks for pain management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Posterior/lateral rib or vertebral fractures
* Pancreatitis or pancreatic cancer
* Renal colic
* Back pain

Exclusion Criteria:

* Unstable vitals
* Infection or open wound over insertion site
* Prior allergic reaction to local anesthetic
* Pregnant females
* Patients \<18 years old
* Altered mentation

Where it's running

  • Crozer Chester Medical Center
    Upland, Pennsylvania, United States
    Recruiting
  • University Hospital
    San Antonio, Texas, United States
    Recruiting
  • Baylor Scott & White
    Temple, Texas, United States
    Recruiting
  • Crozer Chester Medical Center
    Ridley Park, Pennsylvania, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Morgan Ritz, MD — University of Texas Health Science Center San Antonio
  • Study coordinator: Morgan Ritz, MD
  • Email: ritzm@uthscsa.edu
  • Phone: 972-757-2495

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.